Results 291 to 300 of about 16,617,738 (336)

High-throughput screening for efficient microbial biotechnology.

Current Opinion in Biotechnology, 2020
Microbial systems have been widely studied and exploited through genetic engineering to address industrial needs and societal challenges. However, owing to their complexity, singular approaches often do not yield desired or optimal results, pushing ...
Aditya P. Sarnaik, Arren Liu, D. R. Nielsen, Arul M. Varman   +3 more
semanticscholar   +1 more source

High-throughput screening technologies

2003
In the past 5 years the world of high-throughput screening (HTS), which targets lead discovery for both pharmaceutical and agrochemical applications, is in a highly rapid developmental stage. Today, restructuring the drug discovery programs to develop highest performance is a key issue of pharmaceutical companies.
openaire   +2 more sources

A General Two‐Step Strategy–Based High‐Throughput Screening of Single Atom Catalysts for Nitrogen Fixation

Small Methods, 2018
Electrocatalytic or photocatalytic N2 reduction holds great promise for green and sustainable NH3 production under ambient conditions, where an efficient catalyst plays a crucial role but remains a long‐standing challenge.
Chongyi Ling, Yi-Xin Ouyang, Qiang Li, Xiaowan Bai, X. Mao, Aijun Du, Jinlan Wang   +6 more
semanticscholar   +1 more source

Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery

Nature Biomedical Engineering, 2023
Luke H. Rhym, R. Manan, Antonius Koller, Georgina Stephanie, Daniel G. Anderson   +4 more
semanticscholar   +1 more source

High-throughput screening

Drug Discovery Today, 2000
, Grepin, , Pernelle
openaire   +2 more sources

Computational high-throughput screening of electrocatalytic materials for hydrogen evolution

Nature Materials, 2006
J. Greeley, T. Jaramillo, J. Bonde, I. Chorkendorff, J. Nørskov   +4 more
semanticscholar   +1 more source

High-Throughput Screening

2014
Ion channels are a class of proteins that are attractive human, animal, and crop health targets. Ion channels can be considered high-gain (physiologically speaking), high-reward (therapeutic benefit) and high technology (difficult assay development) drug targets.
Alexander Böcker, Sabine Schaertl, Stephen D. Hess   +2 more
openaire   +1 more source

Identifying a highly efficient molecular photocatalytic CO2 reduction system via descriptor-based high-throughput screening

Nature Catalysis
Yangguang Hu, Can Yu, Song Wang, Qian Wang, M. Reinhard, Guozhen Zhang, Fei Zhan, Hao Wang, Dean Skoien, Thomas Kroll, Pei Su, Lei Li, Ao-Bo Chen, Guangyu Liu, Hai-Feng Lv, D. Sokaras, Chao Gao, Jun Jiang, Ye Tao, Yujie Xiong   +19 more
semanticscholar   +1 more source

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Nature Medicine, 2015
Hui Gao, Joshua M Korn, S. Ferretti, J. Monahan, Youzhen Wang, Mallika Singh, Chao Zhang, C. Schnell, Guizhi Yang, Yun Zhang, O. A. Balbin, S. Barbe, H. Cai, Fergal P. Casey, S. Chatterjee, Derek Y. Chiang, S. Chuai, Shawn Cogan, S. Collins, Ernesta Dammassa, N. Ebel, M. Embry, J. Green, A. Kauffmann, C. Kowal, R. Leary, J. Lehar, Ying Liang, Alice T. Loo, Edward G. Lorenzana, E. Mcdonald, M. Mclaughlin, J. Merkin, R. Meyer, Tara L. Naylor, M. Patawaran, Anupama Reddy, Claudia Röelli, David A. Ruddy, Fernando Salangsang, F. Santacroce, Angad P. Singh, Yan Tang, W. Tinetto, Sonja Tobler, Roberto Velazquez, K. Venkatesan, Fabian Von Arx, Hui-Qin Wang, Zongyao Wang, M. Wiesmann, D. Wyss, Fiona Xu, H. Bitter, P. Atadja, E. Lees, F. Hofmann, E. Li, N. Keen, R. Cozens, M. R. Jensen, Nancy K. Pryer, J. Williams, W. Sellers   +63 more
semanticscholar   +1 more source

Social determinants of health and US cancer screening interventions: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Ariella Korn
exaly